Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Seminars in Ophthalmology|May 14, 2009
Conjunctival melanomas: can the cancer stem cell hypothesis be applied?Jessica Ciralsky, Kathryn ColbySeminars in Ophthalmology|December 22, 2007
Congenital corneal opacities: a review with a focus on geneticsJessica Ciralsky, Kathryn ColbyCurrent Opinion in Ophthalmology|November 20, 2013
Ultraviolet-blocking intraocular lenses: fact or fictionEdward Lai, Benjamin Levine, Jessica CiralskyCornea|February 24, 2005
Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbitsElias Aliprandis, Jessica Ciralsky, Hong Lai, et al.Ocular Immunology and Inflammation|July 29, 2010
Keratoprosthesis in autoimmune diseaseJessica Ciralsky, George N Papaliodis, C Stephen Foster, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|April 12, 2012
Vitreoretinal surgery in the setting of permanent keratoprosthesisLee Kiang, Kimberly C Sippel, Christopher E Starr, et al.Annals of Neurology|October 9, 2018
Corneal confocal microscopy: Neurologic disease biomarker in Friedreich ataxiaOdelya E Pagovich, Mary L Vo, Zoe Z Zhao, et al.Advances in Radiation Oncology|June 14, 2017
Analysis of patient outcomes following proton radiation therapy for retinoblastomaKent W Mouw, Beow Y Yeap, Paul Caruso, et al.Ophthalmology|March 31, 2022
Bevacizumab in High-Risk Corneal Transplantation: A Pilot Multicenter Prospective Randomized Control TrialThomas H Dohlman, Matthew McSoley, Francisco Amparo, et al.Ophthalmology Science|April 29, 2024
Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal TransplantationThomas H Dohlman, Rohan Bir Singh, Francisco Amparo, et al.Pageof 1